BTG3 and diffuse large B-cell lymphoma: Similarly, a positive ANA test was associated with a slightly greater risk of DLBCL among those with blood draws four or more years prior to diagnosis (OR: 1.99, 95% CI: 1.19–3.34, p = 0.009), compared to those with blood draws closer to diagnosis (OR: 1.30, 95% CI: 0.45–3.72), but the interaction was not significant (pinteraction = 0.54).